Aging delay: of mice and men.

Area of Science:

• Gerontology and drug safety evaluation.

Background:

• Assessing the safety of potential geroprotective drugs in rodents presents significant challenges.
• Rodent models are vital for understanding aging processes and testing interventions.

Purpose of the Study:

• To discuss approaches for long-term assays to identify potent aging delay drugs for human use.
• To prioritize methods that efficiently evaluate both carcinogenic safety and life-spanning potential.

Main Methods:

• Focus on long-term assays in rodents.
• Integration of carcinogenic safety evaluation with life-spanning potential assessment.

Main Results:

• Proposed methods offer a time-efficient and economically feasible approach.
• Selection of geroprotective drugs can be optimized through combined safety and efficacy assays.

Conclusions:

• Developing efficient and reliable methods for geroprotector evaluation is essential.
• Combined assessment of carcinogenic potential and lifespan extension provides a feasible strategy for drug selection.